AI-powered pathology solutions provider Aiosyn has announced the release of an AI kidney suite designed to advance research in the field of renal disease. Leveraging cutting-edge deep learning technology, this solution provides biopharma and research organisations with powerful tools for analysing kidney structures and quantifying lesions that impact kidney health.
US-based laboratory Navigate BioPharma Services has announced a strategic collaboration with medical technology company BD (Becton, Dickinson and Company) to develop and commercialise flow cytometry-based companion diagnostics and tools for clinical decisions.
Agilent Technologies and Exact Sciences Corp, a leading provider of cancer screening and diagnostic tests, have announced they have entered into a definitive agreement for the sale of Resolution Bioscience to Exact Sciences.
A new independent report released by UKRI underscores the pivotal role played by UK researchers and innovators in tackling the pandemic.
The European Laboratory Research & Innovation Group (ELRIG) UK has announced the formation of its Engagement Strategy Work Group (ESWG). The group will provide strategic direction and guidance to help ensure the ELRIG community continues to grow and thrive.
Dell Technologies has joined forces with the University of Limerick's Digital Cancer Research Centre to develop an artificial intelligence (AI) platform and digital twin technology to power predictive and diagnostic research in oncology.
The Medical Research Council (MRC) has announced a new £2 million investment supporting researchers to understand and treat cancers with exceptionally poor survival rates, including of the brain, lung and oesophagus. Four research innovation teams will each receive £500,000 to work across disciplines on high-risk, high-reward projects towards improving outcomes of hard-to-treat cancers.
Randox offers an extensive product offering comprising third-party quality controls and calibrators, interlaboratory data management, external quality assessment, calibration verification and molecular IQC and EQA for infectious disease testing. Randox Quality Control is now set to add eight Quality Controls to its range.
HORIBA UK will be marking its 70th anniversary at IBMS Congress later this month, where delegates are invited to join the celebrations and also to see the company’s newly launched fully automated haemostasis analysers.
Digital pathology firm Paige has joined forces with Microsoft, with the two firms working to transform cancer diagnosis and patient care by building the world’s largest image-based artificial intelligence (AI) models for digital pathology and oncology.
Ibex Medical Analytics (Ibex), which is innovating AI-powered cancer diagnostics, has announced it has closed a $55 million Series C financing round led by 83North. Additional participants in the round were Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital. The financing brings total funding to over $100 million since Ibex’s inception in 2016.
The Institute of Biomedical Science (IBMS) has collaborated with Microsoft to publish a new white paper, ‘Digital Pathology and Integrated Care Systems: Enabling high-quality, equitable digital pathology services across networks, ICSs and nationally.’
BIOHIT HealthCare will be attending IBMS Congress 2023, where the company will showcase its new GastroPanel Quick Test for triaging gastroscopy referrals.
Quest Diagnostics has announced that its AAVrh74 ELISA (CDx) has been granted Breakthrough Device Designation from the US Food and Drug Administration (FDA).
Innovators seeking to bring their products to the NHS are still facing a lengthy and complex process, says the Medical Technology Group (MTG) in its latest 'Deja Review' report, with patients and clinicians missing out on the benefits provided by medical technology.
Scarborough Hospital in North Yorkshire is the latest institute affected by aerated concrete, with pathology staff currently being relocated to other parts of the building.